Your email has been successfully added to our mailing list.

×
-0.000246083176113536 -0.000246083176113536 0.00205069313427939 0.0115659092773357 8.20277253711009E-05 0.000410138626855854 -0.0035271921909606 -0.00615207940283816
Stock impact report

Novo Study Shows Monthly Hemophilia Drug Reduced Bleeding [BNN Bloomberg (Canada)]

ROCHE HOLDING LTD S/ADR (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
Company Research Source: BNN Bloomberg
Both weekly and monthly dosing with the compound, Mim8, reduced bleeding compared with no prophylaxis and with trial participants' own previous experience with other drugs, the Danish drugmaker said on Monday. About 95% of patients who got monthly shots of Mim8 didn't need to be treated for bleeding, compared to none of those who didn't have prophylaxis, Novo said. Novo and competitors are racing to develop new medicines for hemophilia A, a genetic disorder in which blood doesn't clot as it should. Preventing at least 80% of patients from needing to be treated for bleeding is a key determiner of whether Mim8 will be able to challenge rivals such as Roche Holding AG's Hemlibra, Jefferies analysts wrote before the results were released. Novo said it aims to submit Mim8 for its first regulatory approval toward the end of this year. ©2024 Bloomberg L.P. Top Picks Show less Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
RHHBY alerts

from News Quantified
Opt-in for
RHHBY alerts

from News Quantified